Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Dedifferentiated liposarcoma with homologous lipoblastic differentiation: expanding the spectrum to include low-grade tumours.

Liau JY, Lee JC, Wu CT, Kuo KT, Huang HY, Liang CW.

Histopathology. 2013 Apr;62(5):702-10. doi: 10.1111/his.12068. Epub 2013 Feb 21.

PMID:
23425231
2.

Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.

Mariño-Enríquez A, Hornick JL, Dal Cin P, Cibas ES, Qian X.

Cancer Cytopathol. 2014 Feb;122(2):128-37. doi: 10.1002/cncy.21362. Epub 2013 Nov 12.

3.

Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.

Mariño-Enríquez A, Fletcher CD, Dal Cin P, Hornick JL.

Am J Surg Pathol. 2010 Aug;34(8):1122-31. doi: 10.1097/PAS.0b013e3181e5dc49.

PMID:
20588177
4.

Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?

Le Guellec S, Chibon F, Ouali M, Perot G, Decouvelaere AV, Robin YM, Larousserie F, Terrier P, Coindre JM, Neuville A.

Am J Surg Pathol. 2014 Mar;38(3):293-304. doi: 10.1097/PAS.0000000000000131.

PMID:
24525499
5.

Pleomorphic liposarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic study of 32 additional cases.

Wang L, Ren W, Zhou X, Sheng W, Wang J.

Pathol Int. 2013 Nov;63(11):523-31. doi: 10.1111/pin.12104.

PMID:
24274714
6.

Primary cardiac dedifferentiated liposarcoma with homologous and heterologous differentiation: a case report.

He D, Chen M, Chen H, Liao D, Wang X, Zhang Z, Zhang H.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9662-6. eCollection 2015.

7.
8.

Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours.

Aleixo PB, Hartmann AA, Menezes IC, Meurer RT, Oliveira AM.

J Clin Pathol. 2009 Dec;62(12):1127-35. doi: 10.1136/jcp.2009.070201.

PMID:
19946100
9.
10.

MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.

Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagacé R, Aurias A, Hostein I, Coindre JM.

Am J Surg Pathol. 2005 Oct;29(10):1340-7.

PMID:
16160477
11.

Cutaneous and subcutaneous pleomorphic liposarcoma: a clinicopathologic study of 29 cases with evaluation of MDM2 gene amplification in 26.

Gardner JM, Dandekar M, Thomas D, Goldblum JR, Weiss SW, Billings SD, Lucas DR, McHugh JB, Patel RM.

Am J Surg Pathol. 2012 Jul;36(7):1047-51. doi: 10.1097/PAS.0b013e3182517b96.

PMID:
22472959
12.
13.

Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.

Italiano A, Bianchini L, Gjernes E, Keslair F, Ranchere-Vince D, Dumollard JM, Haudebourg J, Leroux A, Mainguené C, Terrier P, Chibon F, Coindre JM, Pedeutour F.

Clin Cancer Res. 2009 Sep 15;15(18):5696-703. doi: 10.1158/1078-0432.CCR-08-3185. Epub 2009 Sep 8.

14.

Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.

Weaver J, Downs-Kelly E, Goldblum JR, Turner S, Kulkarni S, Tubbs RR, Rubin BP, Skacel M.

Mod Pathol. 2008 Aug;21(8):943-9. doi: 10.1038/modpathol.2008.84. Epub 2008 May 23.

16.

Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases.

Boland JM, Weiss SW, Oliveira AM, Erickson-Johnson ML, Folpe AL.

Am J Surg Pathol. 2010 Jun;34(6):837-43. doi: 10.1097/PAS.0b013e3181dbf2f7.

PMID:
20431480
17.

Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.

Chung L, Lau SK, Jiang Z, Loera S, Bedel V, Ji J, Weiss LM, Chu PG.

Am J Surg Pathol. 2009 Nov;33(11):1594-600. doi: 10.1097/PAS.0b013e3181accb01.

PMID:
19574885
18.

Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.

Saâda-Bouzid E, Burel-Vandenbos F, Ranchère-Vince D, Birtwisle-Peyrottes I, Chetaille B, Bouvier C, Château MC, Peoc'h M, Battistella M, Bazin A, Gal J, Michiels JF, Coindre JM, Pedeutour F, Bianchini L.

Mod Pathol. 2015 Nov;28(11):1404-14. doi: 10.1038/modpathol.2015.96. Epub 2015 Sep 4.

19.

HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.

Italiano A, Bianchini L, Keslair F, Bonnafous S, Cardot-Leccia N, Coindre JM, Dumollard JM, Hofman P, Leroux A, Mainguené C, Peyrottes I, Ranchere-Vince D, Terrier P, Tran A, Gual P, Pedeutour F.

Int J Cancer. 2008 May 15;122(10):2233-41. doi: 10.1002/ijc.23380.

20.

Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.

Grifasi C, Calogero A, Carlomagno N, Campione S, D'Armiento FP, Renda A.

World J Surg Oncol. 2013 Nov 26;11:305. doi: 10.1186/1477-7819-11-305.

Supplemental Content

Support Center